1Elliott WJ. Cyclic and circadian variations in cardiovascular events[J ] .Am J Hypertens, 2001,14(9) :291.
2Miyata T, Uragami T, Nakamae K. Biomolecule- sensitive hydrogels [ J ] .Adv Drug Del Rev, 2002,54(1) : 79.
3Guse C, Koennings S, Blunk T, et al. Programmable implants- from pulsatile to controlled release[J] . Int J Pha rm, 2006,314(2) : 161.
4Iskakov RM, Kikuchi A, Okano T. Time - program- med pulsatile release of dextran from calcium- alginate gel beads coated with carboxy-n- propylacrylamide copolymers [ J ] .J Control Release, 2002,80(1--3) : 57.
5Ghimire M, Mclnnes FJ, Watson DG, et al. In- vitro/ in - vivo correlation of pulsatile drug release from press - coated tablet formulations: A pharmacoscinti- graphic study in the beagle dog[J] .Eur J Pharm Bio pharm, 2007,67(2) : 515.
6Fan TY, Wei SL, Yan WW, et al. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross linked polyvinylpyrrolidone in the core tablets[J ] .J Control Release, 2001,77(3) : 245.
7Bussemer T, Peppas NA, Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system[J ] ,Eur J Pharm Biopharm ,2003, 56(2) :261.
8Sungthongjeen S, Puttipipatkhachorn S, Paeratakul O,et al. Development of pulsatile release tablets with swelling and rupturable layers[J] .J Control Release, 2004,95(2):147.
9Dashevsky A, Mohamad A. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquaeoat * ECD[J ] . Int J Pharm , 2006,318(1- 2) : 124.
10Krogel I, Bodmeier R. Development of a multifunctional matrix drug delivery system surrounded by an impermeable eylinder[J ] .J Control Release, 1999, 61( 1 2) .43.
